Sunzen Biotech Berhad (KLSE: SUNZEN)

Market Cap	245.00M
Revenue (ttm)	95.12M
Net Income (ttm)	6.03M
Shares Out	777.78M
EPS (ttm)	0.01
PE Ratio	42.96
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	126,100
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.220 - 0.400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 24, 2024

About Sunzen Biotech Berhad

Sunzen Biotech Berhad engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through three segments: Animal Health, Human Health, and Loan Financing. The company provides veterinary machines, pharmaceutical, chemical products, animal health products and equipment, laboratory services, and beauty and cosmetic products. It also manufactures and sells traditional Chinese medicine, herbal health foods, beverages, and other...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Country: Malaysia
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: SUNZEN

Financial Performance

In 2024, Sunzen Biotech Berhad's revenue was 95.12 million, a decrease of -3.07% compared to the previous year's 98.13 million. Earnings were 6.03 million, a decrease of -11.35%.